Demars Financial Group, LLC Abbott Laboratories Transaction History

Demars Financial Group, LLC

$214 Million
Q3 2024

A detailed history of Demars Financial Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Demars Financial Group, LLC holds 2,562 shares of ABT stock, worth $294,015. This represents 0.14% of its overall portfolio holdings.

Number of Shares

2,562

Previous 2,621 2.25%

Holding current value

$294,015

Previous $272,000 7.35%

% of portfolio

0.14%

Previous 0.13%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$100.07 - $118.13 $5,904 - $6,969	-59 Reduced 2.25%	2,562 $292,000
Q2 2024 Jul 19, 2024	SELL	$100.73 - $112.44 $38,579 - $43,064	-383 Reduced 12.75%	2,621 $272,000
Q1 2024 Apr 24, 2024	SELL	$109.52 - $120.96 $3,504 - $3,870	-32 Reduced 1.05%	3,004 $341,000
Q4 2023 Feb 01, 2024	SELL	$90.19 - $110.4 $811 - $993	-9 Reduced 0.3%	3,036 $334,000
Q3 2023 Oct 18, 2023	BUY	$95.53 - $114.62 $8,502 - $10,201	89 Added 3.01%	3,045 $294,000
Q2 2023 Jul 20, 2023	SELL	$100.78 - $112.29 $20,861 - $23,244	-207 Reduced 6.54%	2,956 $322,000
Q1 2023 Apr 20, 2023	SELL	$96.86 - $114.01 $1,259 - $1,482	-13 Reduced 0.41%	3,163 $320,000
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $45,343 - $53,195	-477 Reduced 13.06%	3,176 $348,000
Q3 2022 Oct 21, 2022	SELL	$96.76 - $112.03 $1,838 - $2,128	-19 Reduced 0.52%	3,653 $354,000
Q2 2022 Jul 22, 2022	SELL	$102.07 - $123.37 $2.87 Million - $3.47 Million	-28,112 Reduced 88.45%	3,672 $399,000
Q1 2022 Apr 27, 2022	BUY	$114.02 - $139.04 $354,488 - $432,275	3,109 Added 10.84%	31,784 $3.76 Million
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $48,522 - $59,413	420 Added 1.49%	28,675 $4.04 Million
Q3 2021 Oct 15, 2021	SELL	$116.66 - $129.06 $196,338 - $217,207	-1,683 Reduced 5.62%	28,255 $3.34 Million
Q2 2021 Jul 16, 2021	BUY	$105.79 - $124.53 $131,285 - $154,541	1,241 Added 4.32%	29,938 $3.47 Million
Q1 2021 Apr 13, 2021	SELL	$108.84 - $128.23 $204,945 - $241,457	-1,883 Reduced 6.16%	28,697 $3.44 Million
Q4 2020 Jan 25, 2021	BUY	$105.0 - $114.42 $568,050 - $619,012	5,410 Added 21.49%	30,580 $3.35 Million
Q3 2020 Oct 21, 2020	BUY	$91.64 - $111.29 $1,466 - $1,780	16 Added 0.06%	25,170 $2.74 Million
Q2 2020 Sep 15, 2020	SELL	$76.57 - $98.0 $191 Million - $244 Million	-2,490,205 Reduced 99.0%	25,154 $2.3 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $191 Million - $244 Million	2,491,610 Added 10491.43%	2,515,359 $2.3 Million
Q1 2020 Apr 27, 2020	BUY	$62.82 - $91.86 $7,098 - $10,380	113 Added 0.48%	23,749 $1.87 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $1.86 Million - $2.07 Million	23,636 New	23,636 $2.05 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Demars Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Demars Financial Group, LLC with notifications on news.

Account

Demars Financial Group, LLC Abbott Laboratories Transaction History